Genomictree Inc. (KOSDAQ:228760)
18,000
-1,160 (-6.05%)
Mar 9, 2026, 3:30 PM KST
Genomictree Market Cap
Genomictree has a market cap or net worth of 436.80 billion as of March 9, 2026. Its market cap has increased by 6.91% in one year.
Market Cap
436.80B
Enterprise Value
353.97B
Revenue
3.76B
Ranking
n/a
PE Ratio
n/a
Stock Price
18,000.00
Market Cap Chart
Since April 5, 2017, Genomictree's market cap has increased from 59.00B to 436.80B, an increase of 640.35%. That is a compound annual growth rate of 25.15%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SillaJen | 477.93B |
| BINEX | 440.77B |
| Anterogen.Co.,Ltd. | 433.26B |
| GC Cell | 392.21B |
| Green Cross Holdings | 637.89B |
| Bioneer | 325.73B |
| JETEMA, | 321.22B |
| Helixmith | 294.70B |